Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

被引：0

作者：

Porcari, Aldostefano ^{[1
]}

Cappelli, Francesco ^{[2
]}

Nitsche, Christian ^{[3
]}

Tomasoni, Daniela ^{[4
]}

Sinigiani, Giulio ^{[5
]}

Longhi, Simone ^{[6
]}

Bordignon, Luca ^{[7
]}

Masri, Ahmad ^{[8
]}

Serenelli, Matteo ^{[9
]}

Urey, Marcus A. ^{[10
]}

Musumeci, Beatrice ^{[11
]}

Cipriani, Alberto ^{[12
]}

Canepa, Marco ^{[13
]}

Eslam, Roza Badr ^{[14
]}

Kronberger, Christina ^{[3
]}

Chimenti, Cristina ^{[15
]}

Zampieri, Mattia ^{[2
]}

Allegro, Valentina ^{[7
]}

Razvi, Yousuf ^{[16
]}

Patel, Rishi ^{[17
]}

Ioannou, Adam ^{[17
]}

Rauf, Muhammad U. ^{[17
]}

Petrie, Aviva ^{[18
]}

Whelan, Carol ^{[19
,20
]}

Emdin, Michele ^{[21
]}

Metra, Marco ^{[22
]}

Merlo, Marco ^{[7
]}

Sinagra, Gianfranco ^{[7
]}

Hawkins, Philip ^{[17
]}

Solomon, Scott ^{[23
]}

Gillmore, Julian ^{[17
]}

Fontana, Marianna ^{[17
]}

机构：

[1] UCL, Royal Free Hosp NHS Fdn Trust, Natl Amyloidosis Ctr, Div Med, London, England

[2] Univ Florence, Careggi Univ Hosp, Cardiomyopathy Unit, Florence, Italy

[3] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria

[4] Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Cardiol, ASST Spedali Civili, London, England

[5] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy

[6] IRCCS Azienda Osped Univ Bologna, Cardiol Unit, Bologna, Italy

[7] Univ Trieste, Azienda Sanit Univ Giuliano Isontina, Cardiovasc Dept, Ctr Diag & Treatment Cardiomyopathies, Trieste, Italy

[8] OHSU, Knight Cardiovasc Inst, Portland, OR USA

[9] Ferrara Univ Hosp, Cardiol Ctr, Porto Recanati, Italy

[10] Univ Calif San Diego, Med Ctr, Dept Med, La Jolla, CA USA

[11] Sapienza Univ, Fac Med & Psychol, Dept Clin & Mol Med, Rome, Italy

[12] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy

[13] Univ Genoa, Cardiovasc Unit, Genoa, Italy

[14] Med Univ Vienna, Div Cardiol, Vienna, Austria

[15] Sapienza Univ Rome, Policlin Umberto 1, Dept Cardiovasc Resp Dis Nephrol Anesthesiol & Ge, Rome, Italy

[16] Royal Free Hosp, London, England

[17] Royal Free Hosp, Natl Amyloidosis Ctr, London, England

[18] UCL, London, England

[19] Natl Amyloidosis Ctr, London, England

[20] UCL, Royal Free Hosp, Div Med, London, England

[21] Fdn Gabriele Monasterio, Cardiol Div, Pisa, Italy

[22] Univ Brescia, Cardiol Div, Brescia, Italy

[23] Brigham & Womens Hosp, Cardiovasc Dept, 75 Francis St, Boston, MA 02115 USA

来源：

CIRCULATION | 2023年 / 148卷 / 25期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

23010

引用

页码：E303 / E303

页数：1

共 50 条

[1] Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy
Nalbandian, A.
Teruya, S.
Smiley, D.
Helmke, S.
Yarmohammadi, H.
Maurer, M.
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 35 - 36
[2] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy
Byer, Stefano H.
Sivamurugan, Aravinthasamy
Grewal, Udhayvir S.
Fradley, Michael G.
Dominic, Paari
AMERICAN JOURNAL OF CARDIOLOGY, 2025, 243 : 15 - 18
[3] Sodium-glucose cotransporter 2 inhibitors use and outcomes in transthyretin amyloid cardiomyopathy
Jaiswal, Vikash
Hanif, Muhammad
Jaiswal, Akash
Sundas, F. N. U.
Mattumpuram, Jishanth
Fonarow, Gregg
CIRCULATION, 2024, 150
[4] Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy
Maccallini, M.
Barge-Caballero, G.
Barge-Caballero, E.
Lopez-Canoa, J. N.
Enriquez-Vazquez, D.
Couto-Mallon, D.
Paniagua-Martin, M. J.
Vazquez-Rodriguez, J. M.
Crespo-Leiro, M.
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 362 - 362
[5] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
Liebers, David T.
Ebina, Wataru
Iosifescu, Dan V.
HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
[6] Sodium-glucose cotransporter 2 inhibitors in patients with transthyretin amyloid cardiomyopathy - results from a patient series
Alves Da Silva, P. Pedro
Agostinho, J. R.
Brito, J.
Valente-Silva, B.
Garcia, A. B.
Oliveira, C.
Martins, A. M.
Raposo, M.
Gregorio, C.
Morais, P.
Conceicao, I.
Brito, D.
Pinto, F. J.
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 198 - 198
[7] Gout and sodium-glucose cotransporter-2 inhibitors
Lai, Shih-Wei
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
[8] Sodium-glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: Analyses of short-term efficacy and safety
Lang, Frederick M.
Teruya, Sergio
Weinsaft, Ariel
Cuomo, Margaret
Santos, Alfonsina Mirabal
Nalbandian, Ani
Bampatsias, Dimitrios
Maurer, Mathew S.
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 938 - 947
[9] Sodium-glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta-analysis
Karakasis, Paschalis
Theofilis, Panagiotis
Patoulias, Dimitrios
Schuermans, Art
Vlachakis, Panayotis K.
Klisic, Aleksandra
Rizzo, Manfredi
Fragakis, Nikolaos
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025,
[10] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
Anan, Go
Kikuchi, Daisuke
Hirose, Takuo
Ito, Hiroki
Nakayama, Shingo
Mori, Takefumi
KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928

← 1 2 3 4 5 →